Business Wire

KIOXIA-CORPORATION

Share
Kioxia Earns Imperial Invention Prize From the 2020 National Commendation for Invention

Kioxia Corporation , a world leader in memory solutions, announced today it was awarded the 2020 Imperial Invention Prize from the National Commendation for Invention for the company’s Invention of high Density 3D Flash Memory Device and Manufacturing Method Thereof (patent no. 5016832), which greatly increases memory capacity and decreases manufacturing costs.

The prize was organized by the Japan Institute of Invention and Innovation and demonstrates the importance of flash memory for data storage in applications ranging from smart phones to data centers. The National Commendation for Invention awards recognize outstanding inventions, ideas or designs that have achieved or are expected to achieve substantial results due to their excellence. The Imperial Invention Prize is the program’s highest-ranking award.

Awardees (Kioxia employee unless otherwise indicated)

Imperial Invention Prize:

  • Masaru Kito, Group Manager, Advanced Memory Development Center
  • Hideaki Aochi, Senior Expert, Institute of Memory Technology Research and Development
  • Ryota Katsumata, Assistant to General Manager, Advanced Memory Development Center
  • Masaru Kido, Chief Specialist, Memory Development Strategy Division
  • Hiroyasu Tanaka, Chief Specialist, Advanced Memory Development Center
  • Akihiro Nitayama (former Toshiba Corporation)

Implementation Achievement Award:
Nobuo Hayasaka, President and CEO

Kioxia’s three-dimensional flash memory technology has also been recognized with the 2019 Education, Culture, Sports, Science and Technology Minister’s Prize in Local Commendation for Invention of Chubu, and received the 2021 IEEE Andrew S. Grove Award for pioneering and sustained contributions to high-density, three-dimensional flash memory.

Conventional two-dimensional flash memory technology arranges cells in a two-dimensional structure where the memory cell, the minimum unit for storing data, is placed in a planar direction. Miniaturizing memory cells increases the memory capacity per unit area, which enables greater capacity as well as lower production costs. However, miniaturization is approaching its physical limits.

Kioxia’s award-winning three-dimensional flash memory technology is a breakthrough approach that greatly simplified the fabrication process for stacking memory cells vertically to realize high-density 3D flash memory. Whereas conventional stacking required repeated deposition and patterning processes for memory cell array fabrication, this technology first stacks the materials for the memory cells and then makes each cell simultaneously using a one-time patterning process, thereby significantly reducing the processing steps.

High-capacity, high-performance three-dimensional flash memory is now the market’s leading technology. After commercializing 48-layer BiCS FLASH™, three-dimensional flash memory in 2015, Kioxia has gone on to mass-produce 64-layer and 96-layer extra-high-density versions.

About Kioxia Group

Kioxia is a world leader in memory solutions, dedicated to the development, production and sale of flash memory and solid state drives (SSDs). In April 2017, its predecessor Toshiba Memory was spun off from Toshiba Corporation, the company that invented NAND flash memory in 1987. The company pioneers cutting-edge memory solutions and services that enrich people's lives and expand society's horizons. Kioxia's innovative 3D flash memory technology, BiCS FLASH™, is shaping the future of storage in high-density applications, including advanced smartphones, PCs, SSDs, automotive and data centers.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Debiopharm Forges AI-powered Alliance With NetTargets to Pioneer Dual-payload ADCs Against Drug-resistant Cancers30.10.2025 14:00:00 CET | Press release

An Alliance to Combat Resistance: Debiopharm and NetTargets will collaborate to develop next-generation, dual-payload Antibody-Drug Conjugates (ADCs) designed to overcome acquired resistance mechanisms in difficult-to-treat cancers. AI-Powered Precision: The collaboration combines NetTargets' proprietary AI discovery platform—to identify synergistic drug pairings—with Debiopharm’s MLINK Duo technology for coordinated delivery of two distinct warheads on a single ADC. Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based, biopharmaceutical company dedicated to developing innovative therapies that respond to high unmet medical needs, today announced a strategic research collaboration with NetTargets (www.net-targets.com), a South Korean biotech company specializing in AI-enhanced systems biology for drug discovery, to rationally design and advance the discovery of novel, synergistic drug combinations for Debiopharm’s next-generation Antibody-Drug Conjugates (ADCs). This allianc

Bending Spoons Raises $710M for Continued Investment and Growth30.10.2025 14:00:00 CET | Press release

Bending Spoons, one of Europe’s leading technology companies, today announced it has raised $710 million in equity at a pre-money valuation of $11 billion. The round was led by accounts advised by T. Rowe Price Investment Management, Inc., with participation from Baillie Gifford, Cox Enterprises, Durable Capital Partners, Fidelity Management & Research Company, Foxhaven Asset Management, and Radcliff, among others. Goldman Sachs International acted as sole placement agent and Clifford Chance served as legal advisor to the transaction. Notarial advisory services were provided by ZNR Notai. “This moment is a validation of a decade’s worth of work and it serves as an important recognition of what we’ve accomplished at Bending Spoons so far. We remain early in our journey and have ambitious plans for continued investment and growth,” shares Luca Ferrari, co-founder and CEO of Bending Spoons. “We’re proud to bring on some of the world’s finest investors who believe in our approach to value

Owlet® Strengthens Market Leadership as Dream Sight™ Becomes the First Baby Monitor Awarded the SGS Cybersecurity Mark30.10.2025 13:45:00 CET | Press release

Earning the first-ever SGS Cybersecurity Mark in the baby monitor category, Owlet reinforces its leadership in safety, security, privacy, and innovation. Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announced that its newest video monitoring device, Dream Sight, is the first and only baby monitor to earn an SGS Cybersecurity Mark, a global certification that recognizes the highest standards in international cybersecurity and privacy. Dream Sight was tested by Brightsight, an SGS company and global leader in cybersecurity evaluations. For parents, this independent recognition provides extra reassurance that Owlet delivers trusted digital solutions backed by strong encryption, secure data management, and advanced privacy safeguards. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251106669800/en/ Owlet's Dream Sight is the first and only baby monitor to earn an SGS Cybersecu

Crown Bioscience Achieves Second CLIA Certification of 2025 at Suzhou Laboratory30.10.2025 13:30:00 CET | Press release

Crown Bioscience, a global contract research organization (CRO) headquartered in the United States and part of JSR Life Sciences and Japan-based JSR Corporation, today announced that its Suzhou, China laboratory has received Clinical Laboratory Improvement Amendments (CLIA) certification. This achievement marks the company’s second CLIA certification in 2025, following its San Diego facility earlier this year, underscoring Crown Bioscience’s continued commitment to expanding its global network of compliant, clinical-grade laboratories. Regulated by the Centers for Medicare and Medicaid Services (CMS), CLIA certification sets the highest federal standards for laboratory accuracy, reliability, and quality. The designation affirms that Crown Bioscience’s Suzhou laboratory meets all required compliance benchmarks, providing clients with greater confidence in the biomarker data that supports their clinical development and regulatory submissions. ‘’Earning a second CLIA certification within

SLB OneSubsea Secures EPC Contracts from PTTEP for Two Deepwater Projects Offshore Malaysia30.10.2025 13:30:00 CET | Press release

Integrated subsea production systems will help unlock important oil and gas reserves Global energy technology company SLB (NYSE: SLB) announced today the award of two sizeable engineering, procurement, and construction (EPC) contracts by PTT Exploration and Production Public Company Limited (PTTEP) to its OneSubsea™ joint venture. The contracts build on a 20-year collaboration between the two companies and cover the expansion of two fields offshore Malaysia. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251030090404/en/ As part of the EPC contracts, SLB OneSubsea will deliver comprehensive subsea production systems (SPS) for the Alum, Bemban, and Permai deepwater gas fields located in Block H and the Kikeh field, Malaysia’s first deepwater oil project. As part of the EPC contracts, SLB OneSubsea will deliver comprehensive subsea production systems (SPS) for the Alum, Bemban, and Permai deepwater gas fields located in Block

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye